Anti-inflammatory properties of Bridelia ferruginea stem bark: Inhibition of lipopolysaccaride-induced septic shock and vascular permeability

Journal of Ethnopharmacology

Volumn 88, Issue 2-3, 2003, Pages 221-224

  Olajide, Olumayokun A ^a   Okpako, David T ^a   Makinde, Janet M ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Anti inflammatory; Bridelia ferruginea; Lipopolysaccharide; Microvascular permeability; Septic shock; Tumour necrosis factor alpha

Indexed keywords

AMINOTRANSFERASE; BRIDELIA FERRUGINEA EXTRACT; DYE; GALACTOSAMINE; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EUPHORBIA; EVALUATION; INHIBITION KINETICS; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; MEASUREMENT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PLANT STEM; SEPTIC SHOCK; SKIN; UPREGULATION; VASCULARIZATION;

BRIDELIA FERRUGINEA;

EID: 0042330075     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(03)00219-8     Document Type: Article

References (19)

1. Cimanga K., De-Bruyne T., Apers S., Pieters L., Totte M.J., Kambu K., Tona L., Bakana P., van Ufford L.Q., Beukelman C., Labadie R., Vlietinck A.J. Complement-inhibiting constituents of Bridelia ferruginea stem bark. Planta Medica. 65:1999;213-217.
2. Cimanga K., Ying L., De-Bruyne T., Apers S., Cos P., Hermans N., Bakana P., Tona L., Kambu K., Kalenda D.T., Pieters L., Berghe D.V., Vlientick A.J. Radical scavenging and xanthine oxidase inhibitory activity of phenolic compounds from Bridelia ferruginea stem bark. Journal of Pharmacy and Pharmacology. 53:2001;757-761.
3. De-Bruyne T., Cimanga K., Pieters L., Claeys M., Dommisse R., Vlientick A.J. Gallocatechin-(4-0-7)-epigallocatechin, a new biflavonoid isolated from Bridelia ferruginea. Natural Products Letters. 11:1998;47-52.
4. Dinarello C.A. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. Journal of Biological Regulators and Homeostatic Agents. 11:1997;91-103.
5. Fujii E., Irie K., Ogawa A., Ohba K., Muraki T. Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. European Journal of Pharmacology. 297:1996;L675-L682.
6. Fujii E., Yoshioka T., Ishida H., Irie K., Muraki T. Evaluation of iNOS dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide. British Journal of Pharmacology. 130:2000;90-94.
7. Gantner F., Uhlig S., Wendel A. Quinine inhibits release of tumour necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. European Journal of Pharmacology. 29:1995;353-355.
8. Goldbach J.M., Roth J., Storr B., Zeisberger E. Influence of pentoxifylline on fevers induced by bacterial lipopolysaccharide and tumour necrosis factor-α in guinea pigs. European Journal of Pharmacology. 319:1997;273-278.
9. Irie K., Fujii E., Ishida H., Wada K., Suganuma T., Nishikori T., Yoshioka T., Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin. British Journal of Pharmacology. 133:2001;237-242.
10. Iwu, M.M., 1993. Handbook of African Medicinal Plants. CRC Press, Boca Raton, FL, pp. 133-135.
11. Le May L.G., Vander J., Kluger M.J. The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin-6 (IL-6) and tumour necrosis factor (TNF) in the rat. Cytokine. 2:1990;300.
12. Leist M.F., Gantner F., Bohlinger I., Tiegs G., Germann P.G., Wendel A. Tumour necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. American Journal of Pathology. 146:1995;1220.
13. Olajide O.A., Makinde J.M., Awe S.O. Effects of the aqueous extract of Bridelia ferruginea stem bark on carrageenan-induced oedema and granuloma formation in rats and mice. Journal of Ethnopharmacology. 66:1999;113-117.
14. Olajide O.A., Makinde J.M., Okpako D.T., Awe S.O. Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark. Journal of Ethnopharmacology. 71:2000;153-160.
15. Oliver-Bever, B., 1986. Medicinal Plants in Tropical West Africa. Cambridge University Press, London, p. 260.
16. Reitman S., Frankel S. A colorimetric method for the determination of serum GOT and GPT. American Journal of Clinical Pathology. 28:1957;56-63.
17. Sekut L., Yarnall D., Stimpson S.A., Noel L.S., Bateman-Fite R., Clark R.L., Brackeen M.F., Menius J.A., Connolly K.M. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clinical and Experimental Immunology. 100:1995;126-132.
18. Tiegs G., Wolter M., Wendel A. Tumour necrosis factor is a terminal mediator in D-galactosamine endotoxin-induced hepatitis in mice. Biochemical Pharmacology. 38:1989;627.
19. Wada K., Fujii E., Ishida H., Yoshioka T., Muraki T. Effect of lipoteichoic acid on dermal vascular permeability in mice. Journal of Pharmacology and Experimental Therapeutics. 294:2000;280-286.